Henan Taloph Pharmaceutical Stock Co Ltd

SHG:600222 China Drug Manufacturers - Specialty & Generic
Market Cap
$572.54 Million
CN¥4.20 Billion CNY
Market Cap Rank
#11236 Global
#2606 in China
Share Price
CN¥7.32
Change (1 day)
+0.00%
52-Week Range
CN¥4.91 - CN¥8.58
All Time High
CN¥10.35
About

Henan Taloph Pharmaceutical Stock Co.,Ltd engages in the research, development, and sale of pharmaceutical preparations and Chinese herbal medicines in China. Its principal products include Shuanghuanglian oral liquid series, Shuangjinlian mixture, pediatric Qingrezhike oral liquid, Huoxiangzhengqi mixture, Danshen and Wuzi Yanzong oral liquid, Shengmaiyin, pediatric compound chicken gizzard chew… Read more

Henan Taloph Pharmaceutical Stock Co Ltd (600222) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: 0.014x

Based on the latest financial reports, Henan Taloph Pharmaceutical Stock Co Ltd (600222) has a cash flow conversion efficiency ratio of 0.014x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥22.69 Million) by net assets (CN¥1.65 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Henan Taloph Pharmaceutical Stock Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)

This chart illustrates how Henan Taloph Pharmaceutical Stock Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Henan Taloph Pharmaceutical Stock Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Henan Taloph Pharmaceutical Stock Co Ltd ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Henan Taloph Pharmaceutical Stock Co Ltd (1998–2024)

The table below shows the annual cash flow conversion efficiency of Henan Taloph Pharmaceutical Stock Co Ltd from 1998 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥1.63 Billion CN¥-39.59 Million -0.024x -190.35%
2023-12-31 CN¥1.62 Billion CN¥43.74 Million 0.027x +134.96%
2022-12-31 CN¥1.61 Billion CN¥-124.41 Million -0.077x -237.49%
2021-12-31 CN¥1.78 Billion CN¥99.66 Million 0.056x +16.86%
2020-12-31 CN¥1.53 Billion CN¥73.43 Million 0.048x +51.55%
2019-12-31 CN¥1.31 Billion CN¥41.53 Million 0.032x -63.14%
2018-12-31 CN¥1.39 Billion CN¥119.47 Million 0.086x +459.02%
2017-12-31 CN¥1.51 Billion CN¥23.17 Million 0.015x -67.36%
2016-12-31 CN¥1.50 Billion CN¥70.60 Million 0.047x +43.24%
2015-12-31 CN¥1.50 Billion CN¥49.27 Million 0.033x -56.47%
2014-12-31 CN¥1.19 Billion CN¥89.54 Million 0.075x +1340.44%
2013-12-31 CN¥1.09 Billion CN¥-6.65 Million -0.006x -104.57%
2012-12-31 CN¥656.50 Million CN¥87.45 Million 0.133x +79526.32%
2011-12-31 CN¥628.89 Million CN¥105.20K 0.000x +100.51%
2010-12-31 CN¥609.32 Million CN¥-20.00 Million -0.033x -189.72%
2009-12-31 CN¥586.04 Million CN¥21.45 Million 0.037x +12.00%
2008-12-31 CN¥554.97 Million CN¥18.13 Million 0.033x -20.12%
2007-12-31 CN¥521.57 Million CN¥21.34 Million 0.041x +1149.87%
2006-12-31 CN¥487.05 Million CN¥1.59 Million 0.003x +459.04%
2005-12-31 CN¥471.96 Million CN¥276.30K 0.001x -98.54%
2004-12-31 CN¥455.68 Million CN¥18.25 Million 0.040x +371.94%
2003-12-31 CN¥440.61 Million CN¥3.74 Million 0.008x -51.32%
2002-12-31 CN¥428.30 Million CN¥7.47 Million 0.017x -86.79%
2001-12-31 CN¥416.84 Million CN¥55.03 Million 0.132x +6089.51%
2000-12-31 CN¥410.41 Million CN¥875.36K 0.002x -99.14%
1999-12-31 CN¥401.57 Million CN¥99.32 Million 0.247x +36.58%
1998-12-31 CN¥154.84 Million CN¥28.04 Million 0.181x --